Heart News and Research

RSS

Study sheds light on the prognostic value of blood test for predicting cognitive impairment risk

A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged around the extent to which such tests can accurately predict whether a cognitively healthy individual will go on to develop cognitive impairment-a key symptom of Alzheimer's disease.

15 Jul 2026

Tick-borne viruses show concerning potential for future pandemics

A study led by a University of California, Riverside biomedical scientist shows how a family of tick-borne viruses known as orthonairoviruses can evade immune defenses, offering important insights into emerging infectious disease threats and the potential pandemic risk posed by these viruses.

14 Jul 2026

Micro and nanoplastics in the blood linked to increased heart attack risk factors

People who have suffered a serious heart attack had higher levels of micro and nanoplastics in their blood, compared to patients diagnosed with chronic ischemic heart disease and those who have normal blood vessels supplying the heart, according to a study published in the European Heart Journal today (Wednesday).

14 Jul 2026

New wearable microneedle patch tracks medicine levels in real time

Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs.

14 Jul 2026

New project targets recurrent urinary tract infections using phages

Researchers at the HUN-REN Biological Research Centre, Szeged are participating in a €15 million Horizon Europe program that will investigate the combination of phage therapy and microbiome restoration in a European clinical trial.

14 Jul 2026

Tracking Lassa fever survivors provides crucial clues for future vaccines

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the launch of a research study to understand how Lassa fever survivors fight and overcome Lassa virus infection.

14 Jul 2026

Semaglutide dose may matter more than weight loss for heart health

The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging existing treatment assumptions.

14 Jul 2026

Vaping or smoking found to reduce fitness in young people by 15%

Young people who vape or smoke cigarettes have reduced blood vessel functionality, breathing efficiency and exercise capacity compared to those who have never smoked or vaped, according to a study published today in ERJ Open Research.

14 Jul 2026

A 10-minute evening skincare massage may help women sleep better and feel less anxious

Four weeks of a 10-minute evening cosmetic routine with self-massage improved self-reported sleep quality, state anxiety, mental health, and vitality in women with sleep complaints compared with usual routines. Exploratory wearable data showed longer total and deep sleep on rest days, but the non-randomized design and absence of wearable controls limit causal conclusions.

13 Jul 2026

Vaping reduces fitness and blood vessel function in young adults

13 Jul 2026

Myotonia may play a much larger role in driving muscle damage than previously recognized

For decades, researchers studying myotonic dystrophy type 1 (DM1) have focused on the disease's underlying genetic cause: a mutation that produces a toxic form of RNA, disrupting the normal processing of thousands of genetic messages inside cells.

13 Jul 2026

New genetic reference map accelerates human stem cell research

A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map that details how individual genes control the functions and identities of human stem cells.

13 Jul 2026

Study reveals substantial rise in Latin American dementia rates

A new study led by researchers at Washington University School of Medicine in St. Louis and Newcastle University in the U.K. finds that the share of adults living with dementia rose substantially across several Latin American and Caribbean sites over the past two decades.

13 Jul 2026

Rising tick-borne disease in Canada can trigger heart inflammation

Move over, Lyme disease - there's another tick-borne disease to worry about in Canada. Anaplasmosis, the second most common tick-borne disease in the country, can cause a range of health issues, including myocarditis (inflammation of the heart muscle).

13 Jul 2026

New study tracks early genetic changes in hepatitis E virus

Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.

13 Jul 2026

Gum disease bacteria linked to calcific aortic valve stenosis

Gum disease bacteria may spur calcium buildup in the heart's aortic valve, leading to a common and serious heart valve disease, according to preliminary, independent research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026.

12 Jul 2026

Study links oxalate to systemic inflammation and heart damage

Oxalic acid might do more than just contribute to the formation of kidney stones — it may also be an underappreciated driver of inflammation and heart damage in people with impaired kidney function.

11 Jul 2026

New grant funds Penn State street medicine program for homeless populations

Delivering healthcare services directly to people experiencing homelessness and training the next generation of physicians in street medicine is the goal of a new five-year, $2.5 million grant from the Human Resources and Services Administration, an agency within the U.S. Department of Health and Human Services, to Penn State College of Medicine.

11 Jul 2026

Global hotspots where breast cancer and atrial fibrillation overlap

Investigating breast cancer and atrial fibrillation overlap, this study highlights key risk factors, underscoring the need for integrated prevention approaches.

10 Jul 2026

Off-the-shelf CAR T therapy targets treatment-resistant systemic sclerosis

Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.

9 Jul 2026